freya semaglutide | Home | Freya | All
Description
Discover the science behind this weight loss medication and what to expect on your journey.

Schedule a consultation now!

Long-term methods These methods provide a long-term, permanent reduction in PCOS-related facial hair

Lilly's retatrutide drug delivered 71-pound weight loss and 76% pain reduction in obesity patients with knee osteoarthritis during Phase 3 trials.

Results At 1 year, patients achieved significant weight loss with a median total weight loss (%TWL) of 25.5% and a median excess weight loss (%EWL) of 66.3% compared to 16.6% and 40.8%, respectively, at treatment initiation with BMI reduction of 3.7 kg/m2